# Monopar Therapeutics: Form 8-K, filed Mar 27, 2026

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: 8-K
- Filed: 2026-03-27
- Accepted by EDGAR: Mar 27, 2026, 13:27 ET
- Period: 2026-03-27
- Accession: 0001437749-26-010030
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010030/mnpr20260326_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010030/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000143774926010030/mnpr20260326_8k.htm

Filed Mar 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-010030. Last ingested by Listed: Nov 4, 2026, 20:49 ET. No prices; not investment advice.